Two Mega-Mergers Were Just The Highlights Of A Year Of Major Deals

 
• By Joseph Haas

BMS/Celgene and AbbVie/Allergan were the biggest biopharma deals by dollar value in 2019, and the third and seventh largest ever. The year saw 23 deals valued at $1bn or more, including 20 M&A agreements.

Scrip Perspectives 2019 to 2020
2019 saw two biopharma mega-mergers and 23 deals with upfront value of $1bn or more

More from Deals

More from Business